Shares of Becton Dickinson & Co. BDX rose 1.41% to $173.45 Friday, on what proved to be an all-around great trading session ...

This was the stock's second consecutive day of losses.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, ...

Fintel reports that on May 22, 2025, Citigroup downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from Buy to Neutral. Analyst Price Forecast Suggests 29.78% Upside As of May 7, 2025, the ...

Becton Dickinson gained attention this week with the global launch of its new cell analyzer, integrating advanced spectral and real-time cell imaging technologies. This development coincided with ...

Generation Investment Management's Q1 2025 13F portfolio value dropped to $16.56B. Check out the significant stake increases ...

BD (Becton, Dickinson and Company) announced plans to initiate the XTRACT patient data registry for its Rotarex atherectomy ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

On Thursday, Becton Dickinson (NYSE: BDX) shares faced a revision in their market outlook as Citi analysts adjusted the company’s stock rating and price target.The healthcare company’s stock ...

BD (Becton, Dickinson and Company) has introduced a 'Safe Emergency Seminar' series in India to raise awareness about healthcare worker safety in emergency departments. The initiative brings together ...